Unknown

Dataset Information

Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.


ABSTRACT: Platinum-based chemotherapeutic agents cisplatin and carboplatin are widely used in cancer treatment worldwide and may result in ototoxic hearing loss. The high incidence of cancer and salient ototoxic effects of platinum-based compounds pose a global public health threat. The purpose of this study was twofold. First, to estimate the prevalence of ototoxic hearing loss associated with treatment with cisplatin and/or carboplatin via a systematic review and meta-analysis. Second, to estimate the annual global burden of ototoxic hearing loss associated with exposure to cisplatin and/or carboplatin. For the systematic review, three databases were searched (Ovid Medline, Ovid Embase, and Web of Science Core Collection) and studies that reported prevalence of objectively measured ototoxic hearin

SUBMITTER: Dillard LK 

PROVIDER: S-EPMC9339659 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature